Showing results (711-720 of 843) with videos related to

Sort By:
Pageof 85
Cell Reports|February 6, 2020
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope ImmunizationQifeng Han, Todd Bradley, Wilton B Williams, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
Plos Pathogens|December 3, 2019
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Cell Host & Microbe|July 2, 2014
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangementsKatherine J L Jackson, Yi Liu, Krishna M Roskin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)Stephen Walsh, William O Hahn, Wilton B Williams, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trialsJill Whitley, Christopher Zwolinski, Christian Denis, et al.
The Journal of Clinical Investigation|September 29, 2015
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cellsJulia A M Sung, Joy Pickeral, Liqin Liu, et al.
Cell Host & Microbe|September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodiesThomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
The Journal of Clinical Investigation|March 12, 2014
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1Mattia Bonsignori, Kevin Wiehe, Sebastian K Grimm, et al.
The Journal of Infectious Diseases|August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responsesGenevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
Pageof 85